<!doctype html>

<html lang="en">
<head>
    <meta charset="utf-8">
    <meta content="IE=edge" http-equiv="X-UA-Compatible">
    <meta content="width=device-width, initial-scale=1.0" name="viewport">
    <title>GA TB Reference Guide </title>
    <meta content="GA TB Reference Guide" name="description">
    <meta content="SitePoint" name="author">
    <link href="../assets/uikit.css" rel="stylesheet">
    <link href="../assets/style.css" rel="stylesheet">

</head>

<body>

<div class="uk-container">
    <div class="chapter-header">
        <div class="header-title">
            <div>
                <img src="ic_chart.svg"  class="ic_chapter_icon">
            </div>
            <p class="chapter-title">10. Antituberculosis Antibiotics in Adult Patients with Renal Impairment</p>
        </div>
        <p> <span class="view-in-chapter-highlight"> View in chapter → <span> <a href="5_treatment_of_current_(active)_disease_therapy__c__special_clinical_situations.html#table10"> Special Clinical Situations </a></p>
        <p class="last-updated"><i>Last Updated October 2025</i></p>
    </div>
    <hr>
    <div class="uk-overflow-auto"
         id="table_10_antituberculosis_antibiotics_in_adult_patients_with_renal_impairment">
         <div class="uk-tabs-container">
            <ul class="tabs">
                <li><button class="tab-button active-option" onclick="switchTab(0, event)"> INH</button></li>
                <li><button class="tab-button" onclick="switchTab(1, event)"> Rifampin</button></li>
                <li><button class="tab-button" onclick="switchTab(2, event)"> Ethambutol</button></li>
                <li><button class="tab-button" onclick="switchTab(3, event)"> Pyrazinamide</button></li>
                <li><button class="tab-button" onclick="switchTab(4, event)"> Levofloxacin</button></li>
                <li><button class="tab-button" onclick="switchTab(5, event)"> Moxifloxacin</button></li>
                <li><button class="tab-button" onclick="switchTab(6, event)"> Amikacin</button></li>
                <li><button class="tab-button" onclick="switchTab(7, event)"> Linezolid</button></li>
            </ul>
        </div>

        <h4 class="highlight with-info-icon">Important Note <span class="info-icon" data-tooltip="NOTE: Drug adjustments are based on the creatinine clearance (CrCl) which can be estimated as follows: [(140 – age in yrs)(Ideal body weight in kg) for men (× 0.85 for women)] / [(72)(serum creatinine, mg/dL)] Ideal body weight for men: 50 kg + 2.3 kg per inch over 5 feet Ideal body weight for women: 45.5 kg + 2.3 kg per inch over 5 feet" data-tooltip-position="tooltip-right">i</span></h4>

        <div id="content0" class="option-content active-option">
            <table class="uk-table uk-table-small uk-table-divider">
                <tbody>
                    <tr>
                        <th>Usual Dose (UD) Normal Renal Function</th>
                        <td>300 mg/day</td>
                    </tr>
                    <tr>
                        <th>CrCl 30-90</th>
                        <td>UD</td>
                    </tr>
                    <tr>
                        <th>CrCl <30 or Hemodialysis</th>
                        <td>UD</td>
                    </tr>
                    <tr>
                        <th>Peritoneal Dialysis</th>
                        <td rowspan="8" class="th-no-highlight">Data currently are not available for patients receiving peritoneal dialysis. Until data
                            become available, begin with doses recommended for patients receiving hemodialysis and verify
                            adequacy of dosing using serum concentration monitoring.
                        </td>
                    </tr>
                </tbody>
            </table>
        </div>

        <div id="content1" class="option-content">
            <table class="uk-table uk-table-small uk-table-divider">
                <tbody>
                    <tr>
                        <th>Usual Dose (UD) Normal Renal Function</th>
                        <td>600 mg/day</td>
                    </tr>
                    <tr>
                        <th>CrCl 30-90</th>
                        <td>UD</td>
                    </tr>
                    <tr>
                        <th>CrCl <30 or Hemodialysis</th>
                        <td>UD</td>
                    </tr>
                    <tr>
                        <th>Peritoneal Dialysis</th>
                        <td rowspan="8" class="th-no-highlight">Data currently are not available for patients receiving peritoneal dialysis. Until data
                            become available, begin with doses recommended for patients receiving hemodialysis and verify
                            adequacy of dosing using serum concentration monitoring.
                        </td>
                    </tr>
                </tbody>
            </table>
        </div>

        <div id="content2" class="option-content">
            <table class="uk-table uk-table-small uk-table-divider">
                <tbody>
                    <tr>
                        <th>Usual Dose (UD) Normal Renal Function</th>
                        <td>15-25 mg/kg/day</td>
                    </tr>
                    <tr>
                        <th>CrCl 30-90</th>
                        <td>UD</td> 
                    </tr>
                    <tr>
                        <th>CrCl <30 or Hemodialysis</th>
                        <td>20-25 mg/kg/dose thrice weekly</td>
                    </tr>
                    <tr>
                        <th>Peritoneal Dialysis</th>
                        <td rowspan="8" class="th-no-highlight">Data currently are not available for patients receiving peritoneal dialysis. Until data
                            become available, begin with doses recommended for patients receiving hemodialysis and verify
                            adequacy of dosing using serum concentration monitoring.
                        </td>
                    </tr>
                </tbody>
            </table>
        </div>

        <div id="content3" class="option-content">
            <table class="uk-table uk-table-small uk-table-divider">
                <tbody>
                    <tr>
                        <th>Usual Dose (UD) Normal Renal Function</th>
                        <td>25 mg/kg d (max 2 gm/day)</td>
                    </tr>
                    <tr>
                        <th>CrCl 30-90</th>
                        <td>UD</td> 
                    </tr>
                    <tr>
                        <th>CrCl <30 or Hemodialysis</th>
                        <td>25-35 mg/kg/dose thrice weekly</td>
                    </tr>
                    <tr>
                        <th>Peritoneal Dialysis</th>
                        <td rowspan="8" class="th-no-highlight">Data currently are not available for patients receiving peritoneal dialysis. Until data
                            become available, begin with doses recommended for patients receiving hemodialysis and verify
                            adequacy of dosing using serum concentration monitoring.
                        </td>
                    </tr>
                </tbody>
            </table>
        </div>

        <div id="content4" class="option-content">
            <table class="uk-table uk-table-small uk-table-divider">
                <tbody>
                    <tr>
                        <th>Usual Dose (UD) Normal Renal Function</th>
                        <td>750 mg/day</td>
                    </tr>
                    <tr>
                        <th>CrCl 30-90</th>
                        <td>UD</td>
                    </tr>
                    <tr>
                        <th>CrCl <30 or Hemodialysis</th>
                        <td>750-1000 mg/dose thrice weekly</td>
                    </tr>
                    <tr>
                        <th>Peritoneal Dialysis</th>
                        <td rowspan="8" class="th-no-highlight">Data currently are not available for patients receiving peritoneal dialysis. Until data
                            become available, begin with doses recommended for patients receiving hemodialysis and verify
                            adequacy of dosing using serum concentration monitoring.
                        </td>
                    </tr>
                </tbody>
            </table>
        </div>

        <div id="content5" class="option-content">
            <table class="uk-table uk-table-small uk-table-divider">
                <tbody>
                    <tr>
                        <th>Usual Dose (UD) Normal Renal Function</th>
                        <td>400 mg/day</td>
                    </tr>
                    <tr>
                        <th>CrCl 30-90</th>
                        <td>UD</td>
                    </tr>
                    <tr>
                        <th>CrCl <30 or Hemodialysis</th>
                        <td>UD</td>
                    </tr>
                    <tr>
                        <th>Peritoneal Dialysis</th>
                        <td rowspan="8" class="th-no-highlight">Data currently are not available for patients receiving peritoneal dialysis. Until data
                            become available, begin with doses recommended for patients receiving hemodialysis and verify
                            adequacy of dosing using serum concentration monitoring.
                        </td>
                    </tr>
                </tbody>
            </table>
        </div>

        <div id="content6" class="option-content">
            <table class="uk-table uk-table-small uk-table-divider">
                <tbody>
                    <tr>
                        <th>Usual Dose (UD) Normal Renal Function</th>
                        <td>15 mg/kg/daily or thrice weekly</td>
                    </tr>
                    <tr>
                        <th>CrCl 30-90</th>
                        <td>UD</td>
                    </tr>
                    <tr>
                        <th>CrCl <30 or Hemodialysis</th>
                        <td>15 mg/kg/dose thrice weekly</td>
                    </tr>
                    <tr>
                        <th>Peritoneal Dialysis</th>
                        <td rowspan="8" class="th-no-highlight">Data currently are not available for patients receiving peritoneal dialysis. Until data
                            become available, begin with doses recommended for patients receiving hemodialysis and verify
                            adequacy of dosing using serum concentration monitoring.
                        </td>
                    </tr>
                </tbody>
            </table>
        </div>

        <div id="content7" class="option-content">
            <table class="uk-table uk-table-small uk-table-divider">
                <tbody>
                    <tr>
                        <th>Usual Dose (UD) Normal Renal Function</th>
                        <td>600 mg/day</td>
                    </tr>
                    <tr>
                        <th>CrCl 30-90</th>
                        <td>UD</td>
                    </tr>
                    <tr>
                        <th>CrCl <30 or Hemodialysis</th>
                        <td>UD</td>
                    </tr>
                    <tr>
                        <th>Peritoneal Dialysis</th>
                        <td rowspan="8" class="th-no-highlight">Data currently are not available for patients receiving peritoneal dialysis. Until data
                            become available, begin with doses recommended for patients receiving hemodialysis and verify
                            adequacy of dosing using serum concentration monitoring.
                        </td>
                    </tr>
                </tbody>
            </table>
        </div>

        <ul class="uk-list uk-list-disc">
            <li>Standard doses are given unless there is intolerance.</li>
            <li>The medications should be given after hemodialysis on the day of hemodialysis.</li>
            <li>Monitoring of serum drug concentrations should be considered to ensure adequate drug absorption, without
                excessive accumulation, and to assist in avoiding toxicity.
            </li>
            <li>In patients with 30–50 mL/min creatinine clearance, standard doses are used by experts, but measurement
                of serum concentrations 2 and 6 hours after timed administration can be used to assist with optimizing
                drug dosages.
            </li>
        </ul>
        <p><a href="https://academic.oup.com/cid/article/63/7/e147/2196792">Based on Nahid et al. Clin Infect Dis
            2016;63(7):e147–95, Table 11</a></p>
    </div>
</div>

</body>

<script src="../assets/uikit.js" type="text/javascript"></script>
<script src="../assets/uikit-icons.js" type="text/javascript"></script>
<script src="main.js" type="text/javascript"></script>

</html>
